VN

Vijendra Nandalalji Nagori

Active Director Director DIN 10278820
DIN 10278820 First appointment Aug 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Vijendra Nandalalji Nagori

Data last updated:

Vijendra Nandalalji Nagori is a Director at Bioxeen Pharma Private Limited (since 2023). Bioxeen Pharma Private Limited reported revenue of ₹2.3 Lakh (FY 2024).

DIN 10278820
Primary Designation Director
First Appointment 14 Aug 2023
Oldest Company Age 3 yrs
Largest company Bioxeen Pharma Private Limited · ₹2.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bioxeen Pharma Private Limited U47721MH2023PTC408607
Director14 Aug 20232023₹2.3 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Bioxeen Pharma Private Limited
Premium access

Shareholding and investment profile for Vijendra Nandalalji Nagori

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijendra Nandalalji Nagori

Vijendra Nandalalji Nagori currently holds 1 directorship: Bioxeen Pharma Private Limited (Director, since 14 Aug 2023, revenue ₹2.3 Lakh (FY 2024)).

Vijendra Nandalalji Nagori was first appointed on 14 Aug 2023 as Director at Bioxeen Pharma Private Limited.

The current boards of Vijendra Nandalalji Nagori's companies include Kalpana Dhananjay Ghuge (Bioxeen Pharma Private Limited), Priyanka Gulabrao Ghuge (Bioxeen Pharma Private Limited), Radheshyam Ramkisan Karwa (Bioxeen Pharma Private Limited), Rajendra Shantirao Mule (Bioxeen Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available